Champions Oncology, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Champions Oncology, Inc. announces its Annual Meeting of Stockholders for October 16, 2025, to address director elections, auditor ratification, and executive compensation.
NASDAQ
Champions Oncology, Inc. announces its Annual Meeting of Stockholders on October 16, 2025, to elect directors, ratify auditors, and approve executive compensation.
NASDAQ
Champions Oncology announces its annual stockholders meeting to be held on October 14, 2024, outlining proposals for director elections, auditor ratification, and executive compensation.
NASDAQ
Champions Oncology will hold its annual stockholders meeting on October 14, 2024, to elect directors, ratify the appointment of its accounting firm, and vote on executive compensation.